Dr. Michael DeHart has joined Metrics, Inc. as a new formulation scientist. Dr. DeHart will manage all aspects of personnel and operations related to formulating and manufacturing pharmaceutical materials for Phase I-III clinical trials. He is also responsible for scale up and validation of clinical trial materials, and manufacturing and packaging batches under cGMP guidelines. He will supervise technology transfers and serve as the company’s experimental design expert in both formulation develo...